India-Japan Trade Talks Center On Quick Action On Drug Applications
This article was originally published in PharmAsia News
Executive Summary
Trade authorities in Japan and India are closing in on an agreement that would allow Indian generics to sell their wares in Japan. The India-Japan Comprehensive Economic Partnership Agreement is still being negotiated, but the office of India's prime minister's has discussed the talks with some Indian companies. India seeks Japanese decisions on its drug approval applications within one year, with an understanding the year would not include time Indian firms take to responds to regulatory questions. (Click here for more